StockNews.com Downgrades Amgen (NASDAQ:AMGN) to Buy
Amgen (NASDAQ:AMGN – Get Free Report) was downgraded by research analysts at StockNews.com from a “strong-buy” rating to a “buy” rating in a report issued on Saturday. A number of other research firms have also commented on AMGN. Bank of America increased their price objective on Amgen from $275.00 to $294.00 and gave the company […]
Amgen (NASDAQ:AMGN – Get Free Report) was downgraded by research analysts at StockNews.com from a “strong-buy” rating to a “buy” rating in a report issued on Saturday. A number of other research firms have also commented on AMGN. Bank of America increased their price objective on Amgen from $275.00 to $294.00 and gave the company […]
